The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWarpaint London Regulatory News (W7L)

Share Price Information for Warpaint London (W7L)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 480.00
Bid: 480.00
Ask: 485.00
Change: 0.00 (0.00%)
Spread: 5.00 (1.042%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 480.00
W7L Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of the Acquisition of Retra

30 Nov 2017 08:48

RNS Number : 9608X
Warpaint London PLC
30 November 2017
 

30 November 2017

 

Warpaint London PLC

("Warpaint", the "Company" or the "Group")

 

Completion of the Acquisition of Retra

 

Warpaint London PLC (AIM: W7L), the specialist supplier of colour cosmetics and owner of the W7 brand, is pleased to announce the completion of the acquisition of Retra Holdings Limited.

 

The Company confirms the admission of 12,210,525 new ordinary shares in the Company to trading on AIM earlier today ("Admission"). Following Admission, the total number of shares in issue will be 76,749,125. The Company does not hold any shares in treasury. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

Following Admission, the shareholdings of the Directors of the Company are as follows:

 

 

Director

Total Number of ordinary shares held in the Company

Percentage of issued share capital of the Company

 

Sam Bazini*

 

 20,545,208

 

 

26.77%

 

Eoin Macleod*

 

 20,545,208

 

26.77%

 

Clive Garston

 

 126,315

 

0.16%

 

Neil Rodol

 

 103,961

 

0.14%

 

Paul Hagon

 

 31,145

 

0.04%

 

Keith Sadler

 31,145

0.04%

 

* Including 3,000,000 Ordinary Shares held by the Director's wife

 

Enquiries:

 

Warpaint London PLC

Sam Bazini - Joint Chief Executive Officer

Eoin Macleod - Joint Chief Executive Officer

Neil Rodol - Chief Financial Officer

 

020 3053 8671

 

Stockdale Securities Limited (Nominated Adviser and Broker)

Mark Brown, Antonio Bossi, Ed Thomas - Corporate Finance

Fiona Conroy - Corporate Broking

 

020 7601 6100

 

IFC Advisory Limited (Financial PR & IR)

Tim Metcalfe

Graham Herring

Heather Armstrong

Miles Nolan

020 3053 8671

 

 

About Warpaint London PLC

 

Warpaint London is a colour cosmetics business, based in Iver, Buckinghamshire. It is made up of two divisions: close-out and own-brand. The second and larger own-brand division consists primarily of the Group's flagship brand, W7 - an extremely creative, design-focused cosmetic brand proposition with a focus on the 16-30 age range, delivering high-quality cosmetics at affordable prices. The W7 brand has grown organically since its inception in 2002 and now contains over 500 items which are sold into high street retailers and independent beauty shops across the UK, Europe, Australia and the US. In 2016, W7 was supplied to over 250 customers in more than 50 countries.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQDMMFMRGDGNZG
Date   Source Headline
8th Sep 20227:00 amRNSTrading Update
1st Sep 20227:00 amRNSNotice of Results and Investor Webinar
29th Jun 20227:00 amRNSPMDR / PCA Dealing
28th Jun 20227:00 amRNSDirector/PDMR Dealing
27th Jun 202211:34 amRNSResult of AGM
27th Jun 20227:00 amRNSAGM Statement
31st May 20227:00 amRNSNotice of AGM and Posting of Annual Report
26th Apr 20223:57 pmRNSDividend Timetable
26th Apr 20227:00 amRNSResults for the year ended 31 December 2021
12th Apr 20227:00 amRNSTrading Update and Notice of Results
21st Mar 20221:21 pmRNSHolding(s) in Company
11th Mar 20225:23 pmRNSPMDR / PCA Dealing
2nd Mar 20227:00 amRNSWard & Hagon Contract Renewal and Grant of Options
28th Feb 20224:29 pmRNSHolding(s) in Company
23rd Feb 20224:56 pmRNSHolding(s) in Company
1st Feb 20227:00 amRNSFull Year Trading Update
2nd Nov 20217:00 amRNSTrading Update
22nd Sep 20217:00 amRNSInterim Results
16th Sep 202112:16 pmRNSPrice Monitoring Extension
14th Sep 20219:05 amRNSSecond Price Monitoring Extn
14th Sep 20219:00 amRNSPrice Monitoring Extension
1st Sep 20217:00 amRNSNotice of Results & Investor Webinar
3rd Aug 20217:00 amRNSAppointment of Non-Executive Director
11th Jun 202111:24 amRNSResult of AGM
11th Jun 202111:05 amRNSSecond Price Monitoring Extn
11th Jun 202111:00 amRNSPrice Monitoring Extension
11th Jun 20217:00 amRNSAGM Statement
28th May 202111:01 amRNSTotal Voting Rights
25th May 20213:28 pmRNSGrant of Options and Director/PDMR Shareholding
17th May 202112:34 pmRNSNotice of AGM and Posting of Annual Report
6th May 20213:57 pmRNSExercise of share options, issue of equity and TVR
28th Apr 20217:00 amRNSResults for the year ended 31 December 2020
20th Apr 20214:41 pmRNSSecond Price Monitoring Extn
20th Apr 20214:36 pmRNSPrice Monitoring Extension
20th Apr 20217:00 amRNSTrading Update and Notice of Results
19th Apr 20212:26 pmRNSHolding(s) in Company
8th Mar 20214:37 pmRNSHolding(s) in Company
19th Feb 20217:00 amRNSWard & Hagon Contract Renewal
10th Feb 20212:56 pmRNSHolding(s) in Company
22nd Jan 20214:00 pmRNSTransfer of Shares and Director/PDMR Shareholding
18th Jan 20217:00 amRNSFull Year Trading Update
10th Dec 20203:03 pmRNSHolding(s) in Company
17th Nov 20207:00 amRNSUK Retail Update
23rd Sep 20207:00 amRNSInterim Results
4th Sep 20207:00 amRNSNotice of Results
16th Jul 20207:00 amRNSChange of Advisers
26th Jun 202012:24 pmRNSResult of AGM
26th Jun 20207:00 amRNSAGM Statement
15th Jun 20207:00 amRNSEquity Development Investor Webinar
1st Jun 20204:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.